Surveillance and treatment of primary hepatocellular carcinoma (aka. STOP HCC): protocol for a prospective cohort study of high-risk patients for HCC using GALAD-score
2023 · BMC Cancer · 4 citations
https://doi.org/10.1186/s12885-023-11167-9
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
3
Papers
8
Citations
2
h-index
0
i10-index
Diem Vu Bich Dao is an academic researcher. The author has contributed to research in topics: Hepatitis C virus research & Hepatitis B Virus Studies & Vaccine Coverage and Hesitancy. The author has an h-index of 2, co-authored 3 publications.
https://doi.org/10.1186/s12885-023-11167-9
https://doi.org/10.1186/s12879-024-09326-9
Click to start Chat